Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma

Authors:

JCJ. De Castro
J. De Castro

Publisher website

15 October 2000

journal article
clinical trial
Published by Wiley in Cancer

Vol. 89 (8) , 1706-1713
DOI:10.1002/1097-0142(20001015)89:8<1706::aid-cncr9>3.0.co;2-i
PMID:11042564

Abstract

No abstract available

Keywords

This publication has 21 references indexed in Scilit:

Cancer statistics, 1999
CA: A Cancer Journal for Clinicians, 1999
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma
Cancer, 1996
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
Annals of Oncology, 1996
A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer
British Journal of Cancer, 1996
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
Annals of Oncology, 1996
Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial
British Journal of Cancer, 1995
A Phase II Survival Comparison of Patients with Adenocarcinoma of the Pancreas Treated with 5-Fluorouracil and Calcium Leucovorin Versus a Matched Tumor Registry Control Population
American Journal of Clinical Oncology, 1994
Chemotherapy prolongs survival in inoperable pancreatic carcinoma
British Journal of Surgery, 1994
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
Investigational New Drugs, 1994
Continuous 5-Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II Study
The American Journal of the Medical Sciences, 1988